Pictet Asset Management (Switzerland)’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
CS
PHS
AWA
GE
PVI
Pictet Asset Management (Switzerland)'s SOPH Position: Q2 2022 in Review
Pictet Asset Management (Switzerland) sold out of SOPHiA GENETICS (SOPH) in Q2 2022, closing a stake of 586,303 shares — an estimated $4.53M sold.
Pictet Asset Management (Switzerland) first reported a position in SOPH in Q3 2021 and held it in 3 quarters. The position peaked at $10.8M in Q3 2021. 34 funds tracked by Wall St. Rank hold SOPH as of Q2 2022.
- Pictet Asset Management (Switzerland) reported no remaining SOPHiA GENETICS position as of Q2 2022 after selling out during the quarter.
- Pictet Asset Management (Switzerland) sold 586,303 SOPHiA GENETICS shares in Q2 2022, an estimated $4.53M.
- Pictet Asset Management (Switzerland) first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 3 quarters.
- Pictet Asset Management (Switzerland)'s SOPHiA GENETICS position peaked at $10.8M in Q3 2021.
- 34 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2022.
Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 9 Aug 2022.